HashKey Group and OKX Plan Partnership to Promote Compliant Virtual Asset Innovation in Hong Kong
HONG KONG, Jan. 23, 2024 /PRNewswire/ — HashKey Group (“HashKey” or “the Group”), a leading end-to-end digital asset financial services group in Asia, and OKX, a global leading Web3 technology company and crypto exchange, today announced plans to create a partnership to
HD Map for the Autonomous Vehicles Market to grow by USD 5.38 billion from 2022 to 2027, The rising adoption of cloud-based HD maps to Boost Growth – Technavio
NEW YORK, Jan. 22, 2024 /PRNewswire/ — The HD map for autonomous vehicles market is estimated to grow at a CAGR of 31.48% between 2022 and 2027. The size is forecast to increase by USD 5.38 billion, according to Technavio. The rising adoption of cloud-based HD maps is notably driving growt
Jimmy’s Jazz & Blues Club Features 7x-GRAMMY® Award Nominated Trumpeter & Composer CHIEF ADJUAH (Formerly Christian Scott) on Saturday February 17 at 7 and 9:30 P.M.
7x-GRAMMY® Award Nominated Trumpeter & Composer CHIEF ADJUAH (Formerly Christian Scott) is a two-time Edison Award-Winner who NPR says, “ushers in a new era of jazz.” Chief Adjuah won the 2020 Jazz Journalist Association “Trumpeter of the Year” Award. Tickets for CHIEF A
Eubiotics Market: Global Demand, Growth Analysis & Opportunity Outlook 2022 to 2027 – Technavio
Based on Type, The market share growth by the poultry segment will be significant during the forecast period. NEW YORK, Jan. 22, 2024 /PRNewswire/ — The eubiotics market is set to grow by USD 2.25 billion from 2022 to 2027 progressing at a CAGR of 7.32% during the forecast period. The r
More enterprises secure early spots at CIIE 2024
SHANGHAI, Jan. 22, 2024 /PRNewswire/ — Twenty-three companies had signed up early for the seventh edition in Shanghai on Jan 9. Among them are big names such as PepsiCo, Tesla, 3M and Bayer. “The CIIE facilitates economic and trade cooperation, and has helped PepsiCo know the Chinese mar
European Medicines Agency (EMA) Grants Orphan Drug Designation (ODD) to GC Biopharma’s Treatment for Sanfilippo Syndrome (Type A)
YONGIN, South Korea, Jan. 22, 2024 /PRNewswire/ — GC Biopharma Corp. (006280.KS) announced that the European Medicines Agency (EMA) has granted Orphan Drug Designation (ODD) to its intracerebroventricular (ICV) Enzyme Replacement Therapy (ERT) candidate, GC1130A, designed for Sanfilippo Syndro
TSX Venture Exchange Stock Maintenance Bulletins
VANCOUVER, BC, Jan. 22, 2024 /CNW/ – TSX VENTURE COMPANIES None today 24/01/22 – TSX Venture Exchange Bulletins TSX VENTURE COMPANIES BULLETIN V2024-0232 CANADA NICKEL COMPANY INC. (“CNC”)BULLETIN TYPE: Private Placement-BrokeredBULLETIN DATE: January 22, 2024TSX Venture Tie
Gannex’s Strategic Partner Sagimet Biosciences Announces Positive Topline Results from Phase 2b FASCINATE-2 Clinical Trial of Denifanstat in Biopsy-Confirmed F2/F3 NASH
Denifanstat achieved statistically significant results on primary and multiple secondary endpoints in a 52-week clinical trial of 168 NASH patients with stage 2 or 3 fibrosis – Primary efficacy endpoints: NASH resolution without worsening of fibrosis with ≥2-point reduction in NAS (NAFLD
Real Time Payments Market 2022-2027; USD 55.54 billion Incremental Growth – Technavio
NEW YORK, Jan. 22, 2024 /PRNewswire/ — The real time payments market is estimated to grow by USD 55.54 billion from 2022 to 2027, growing at a CAGR of 31.35%. The market is estimated to show a 29.0% Y-O-Y growth in 2023. The real time payments market is fragmented, owing to the presence of m
Leading with Lifestyle: How Timo Digital Bank is Changing the Financial Game in Vietnam?
HO CHI MINH CITY, Vietnam, Jan. 23, 2024 /PRNewswire/ — As a pioneer in digital banking services, Timo has long been on a mission of continuously setting the benchmark. Starting from free bank transfers and ATM withdrawals 8 years ago, Timo since has focused on connecting communities and foste
